Phosphodiesterase type IV (PDE4)

Phosphodiesterase type IV (PDE4) is an enzyme that catalyzes the hydrolysis of cyclic adenosine monophosphate (cAMP) to its inactive form. It plays a central role in regulating intracellular signaling pathways that depend on cAMP as a second messenger. PDE4 consists of four subtypes: PDE4A, PDE4B, PDE4C, and PDE4D. It is highly expressed in immune cells and the central nervous system. Inhibition of PDE4 leads to increased intracellular levels of cAMP, resulting in anti-inflammatory and neuroprotective effects, but may cause gastrointestinal side effects.

Inhibition of PDE4 leads to increased intracellular levels of cAMP, activating downstream effectors like protein kinase A (PKA), exchange proteins directly activated by cAMP (Epac1/2), and cyclic nucleotide-gated ion channels, modulating inflammation and immune balance.